Table 1 Patient characteristics in the model development cohort by the worst severity during the disease course.

From: Development and validation of a prognostic model for early triage of patients diagnosed with COVID-19

Variable

Supportive care

O2 therapy

Critical care

Mortality

p value

Total

Number of patients

4780 (85.4%)

512 (9.1%)

241 (4.3%)

63 (1.1%)

< 0.001

5596 (100%)

Days to recovery or death, mean (SD)

25.5 (10.3)

30.0 (12.1)

36.3 (16.1)

15.2 (13.4)

< 0.001

25.6 (11.0)

Age

0–9 years

66 (100%)

0 (0%)

0 (0%)

0 (0%)

< 0.001

66 (100%)

10–19 years

203 (99%)

1 (0.5%)

0 (0%)

1 (0.5%)

 

205 (100%)

20–29 years

1087 (98%)

20 (1.8%)

0 (0%)

2 (0.2%)

 

1109 (100%)

30–39 years

546 (97.2%)

11 (2%)

2 (0.4%)

3 (0.5%)

 

562 (100%)

40–49 years

703 (95.1%)

34 (4.6%)

2 (0.3%)

0 (0%)

 

739 (100%)

50–59 years

999 (87.6%)

114 (10%)

15 (1.3%)

12 (1.1%)

 

1140 (100%)

60–69 years

713 (78.7%)

135 (14.9%)

34 (3.8%)

24 (2.6%)

 

906 (100%)

70–79 years

331 (60.7%)

125 (22.9%)

73 (13.4%)

16 (2.9%)

 

545 (100%)

 ≥ 80 years

132 (40.7%)

72 (22.2%)

115 (35.5%)

5 (1.5%)

 

324 (100%)

Sex

Female

2858 (86.9%)

288 (8.8%)

114 (3.5%)

29 (0.9%)

< 0.001

3289 (100%)

Male

1922 (83.3%)

224 (9.7%)

127 (5.5%)

34 (1.5%)

 

2307 (100%)

Pregnancy

No

4752 (85.3%)

512 (9.2%)

241 (4.3%)

63 (1.1%)

0.353

5568 (100%)

Yes

19 (100%)

0 (0%)

0 (0%)

0 (0%)

 

19 (100%)

Missing

9 (100%)

0 (0%)

0 (0%)

0 (0%)

 

9 (100%)

Body mass index (kg/cm2)

 < 18.5

225 (86.9%)

16 (6.2%)

16 (6.2%)

2 (0.8%)

< 0.001

259 (100%)

18.5–23

1660 (89.5%)

127 (6.9%)

46 (2.5%)

21 (1.1%)

 

1854 (100%)

23–25

893 (86.4%)

108 (10.5%)

20 (1.9%)

12 (1.2%)

 

1033 (100%)

25–30

865 (82.8%)

125 (12%)

39 (3.7%)

16 (1.5%)

 

1045 (100%)

 > 30

178 (86%)

20 (9.7%)

5 (2.4%)

4 (1.9%)

 

207 (100%)

Missing

959 (80.1%)

116 (9.7%)

115 (9.6%)

8 (0.7%)

 

1198 (100%)

Subjective fever

Absent

3818 (88.9%)

296 (6.9%)

148 (3.4%)

32 (0.7%)

< 0.001

4294 (100%)

Present

962 (73.9%)

216 (16.6%)

93 (7.1%)

31 (2.4%)

 

1302 (100%)

Cough

Absent

2836 (86.9%)

239 (7.3%)

160 (4.9%)

30 (0.9%)

< 0.001

3265 (100%)

Present

1944 (83.4%)

273 (11.7%)

81 (3.5%)

33 (1.4%)

 

2331 (100%)

Sputum

Absent

3456 (86.7%)

319 (8%)

169 (4.2%)

41 (1%)

< 0.001

3985 (100%)

Present

1324 (82.2%)

193 (12%)

72 (4.5%)

22 (1.4%)

 

1611 (100%)

Dyspnea

Absent

4445 (90.1%)

332 (6.7%)

128 (2.6%)

26 (0.5%)

< 0.001

4931 (100%)

Present

335 (50.4%)

180 (27.1%)

113 (17%)

37 (5.6%)

 

665 (100%)

Sore throat

Absent

3989 (84.4%)

446 (9.4%)

228 (4.8%)

61 (1.3%)

< 0.001

4724 (100%)

Present

791 (90.7%)

66 (7.6%)

13 (1.5%)

2 (0.2%)

 

872 (100%)

Rhinorrhea

Absent

4216 (84.7%)

468 (9.4%)

235 (4.7%)

60 (1.2%)

< 0.001

4979 (100%)

Present

564 (91.4%)

44 (7.1%)

6 (1%)

3 (0.5%)

 

617 (100%)

Myalgia

Absent

4005 (85.6%)

400 (8.6%)

220 (4.7%)

52 (1.1%)

< 0.001

4677 (100%)

Present

775 (84.3%)

112 (12.2%)

21 (2.3%)

11 (1.2%)

 

919 (100%)

Fatigue

Absent

4606 (85.9%)

475 (8.9%)

224 (4.2%)

58 (1.1%)

< 0.001

5363 (100%)

Present

174 (74.7%)

37 (15.9%)

17 (7.3%)

5 (2.1%)

 

233 (100%)

Headache

Absent

3931 (84.8%)

421 (9.1%)

228 (4.9%)

53 (1.1%)

< 0.001

4633 (100%)

Present

849 (88.2%)

91 (9.4%)

13 (1.3%)

10 (1%)

 

963 (100%)

Nausea or vomiting

Absent

4598 (85.9%)

470 (8.8%)

225 (4.2%)

59 (1.1%)

< 0.001

5352 (100%)

Present

182 (74.6%)

42 (17.2%)

16 (6.6%)

4 (1.6%)

 

244 (100%)

Diarrhea

Absent

4354 (85.7%)

446 (8.8%)

223 (4.4%)

57 (1.1%)

0.022

5080 (100%)

Present

426 (82.6%)

66 (12.8%)

18 (3.5%)

6 (1.2%)

 

516 (100%)

Altered consciousness

Absent

4772 (85.8%)

512 (9.2%)

218 (3.9%)

59 (1.1%)

< 0.001

5561 (100%)

Present

8 (22.9%)

0 (0%)

23 (65.7%)

4 (11.4%)

 

35 (100%)

Diabetes mellitus

Absent

4322 (88%)

397 (8.1%)

143 (2.9%)

47 (1%)

< 0.001

4909 (100%)

Present

458 (66.7%)

115 (16.7%)

98 (14.3%)

16 (2.3%)

 

687 (100%)

Hypertension

Absent

3966 (90.2%)

304 (6.9%)

97 (2.2%)

31 (0.7%)

< 0.001

4398 (100%)

Present

814 (67.9%)

208 (17.4%)

144 (12%)

32 (2.7%)

 

1198 (100%)

Heart disease

Absent

4756 (85.9%)

497 (9%)

223 (4%)

61 (1.1%)

< 0.001

5537 (100%)

Present

24 (40.7%)

15 (25.4%)

18 (30.5%)

2 (3.4%)

 

59 (100%)

Asthma

Absent

4682 (85.6%)

495 (9.1%)

228 (4.2%)

63 (1.2%)

0.001

5468 (100%)

Present

98 (76.6%)

17 (13.3%)

13 (10.2%)

0 (0%)

 

128 (100%)

Chronic obstructive pulmonary disease

Absent

4760 (85.7%)

502 (9%)

233 (4.2%)

61 (1.1%)

< 0.001

5556 (100%)

Present

20 (50%)

10 (25%)

8 (20%)

2 (5%)

 

40 (100%)

Chronic kidney disease

Absent

4757 (85.9%)

498 (9%)

225 (4.1%)

61 (1.1%)

< 0.001

5541 (100%)

Present

23 (41.8%)

14 (25.5%)

16 (29.1%)

2 (3.6%)

 

55 (100%)

Cancer

Absent

4679 (85.8%)

490 (9%)

219 (4%)

63 (1.2%)

< 0.001

5451 (100%)

Present

101 (69.7%)

22 (15.2%)

22 (15.2%)

0 (0%)

 

145 (100%)

Chronic liver disease

Absent

4404 (84.9%)

490 (9.4%)

234 (4.5%)

62 (1.2%)

0.033

5190 (100%)

Present

61 (73.5%)

14 (16.9%)

7 (8.4%)

1 (1.2%)

 

83 (100%)

missing

315 (97.5%)

8 (2.5%)

0 (0%)

0 (0%)

 

323 (100%)

Autoimmune disease

Absent

4430 (84.7%)

498 (9.5%)

238 (4.6%)

63 (1.2%)

0.356

5229 (100%)

Present

29 (76.3%)

6 (15.8%)

3 (7.9%)

0 (0%)

 

38 (100%)

missing

321 (97.6%)

8 (2.4%)

0 (0%)

0 (0%)

 

329 (100%)

Dementia

Absent

4355 (86.3%)

463 (9.2%)

166 (3.3%)

62 (1.2%)

< 0.001

5046 (100%)

Present

107 (47.8%)

41 (18.3%)

75 (33.5%)

1 (0.4%)

 

224 (100%)

missing

318 (97.5%)

8 (2.5%)

0 (0%)

0 (0%)

 

326 (100%)

Heart rate (beat/min)

Bradycardia (< 60)

87 (80.6%)

15 (13.9%)

6 (5.6%)

0 (0%)

0.001

108 (100%)

Normal (60–100)

3799 (86.3%)

394 (8.9%)

160 (3.6%)

50 (1.1%)

 

4403 (100%)

Tachycardia (> 100)

784 (81.8%)

102 (10.6%)

61 (6.4%)

12 (1.3%)

 

959 (100%)

Missing

110 (87.3%)

1 (0.8%)

14 (11.1%)

1 (0.8%)

 

126 (100%)

Body temperature (°C)

 < 37.5

4300 (88.0%)

380 (7.8%)

166 (3.4%)

39 (0.8%)

< 0.001

4885 (100%)

37.5–38

349 (75.4%)

70 (15.1%)

36 (7.8%)

8 (1.7%)

 

463 (100%)

38–38.5

74 (54.4%)

31 (22.8%)

21 (15.4%)

10 (7.4%)

 

136 (100%)

38.5 ≥ 38.5

32 (43.8%)

29 (39.7%)

6 (8.2%)

6 (8.2%)

 

73 (100%)

Missing

25 (64.1%)

2 (5.1%)

12 (30.8%)

0 (0%)

 

39 (100%)

Systolic blood pressure (mmHg)

 < 120

1140 (87.3%)

95 (7.3%)

58 (4.4%)

13 (1%)

< 0.001

1306 (100%)

120–129

988 (86.8%)

110 (9.7%)

28 (2.5%)

12 (1.1%)

 

1138 (100%)

130–139

939 (86.7%)

101 (9.3%)

32 (3%)

11 (1%)

 

1083 (100%)

140–159

1190 (84%)

141 (10%)

68 (4.8%)

18 (1.3%)

 

1417 (100%)

 ≥ 160

402 (78.4%)

65 (12.7%)

37 (7.2%)

9 (1.8%)

 

513 (100%)

Missing

121 (87.1%)

0 (0%)

18 (12.9%)

0 (0%)

 

139 (100%)

Diastolic blood pressure (mmHg)

 < 80

1763 (83.9%)

208 (9.9%)

104 (4.9%)

27 (1.3%)

0.266

2102 (100%)

80–89

1557 (86.7%)

156 (8.7%)

61 (3.4%)

22 (1.2%)

 

1796 (100%)

90–99

907 (86%)

102 (9.7%)

36 (3.4%)

10 (0.9%)

 

1055 (100%)

 ≥ 100

432 (85.7%)

46 (9.1%)

22 (4.4%)

4 (0.8%)

 

504 (100%)

Missing

121 (87.1%)

0 (0%)

18 (12.9%)

0 (0%)

 

139 (100%)

Hemoglobin (g/dL)

Anemia

715 (69.8%)

162 (15.8%)

128 (12.5%)

20 (2%)

< 0.001

1025 (100%)

Normal*

2137 (84.7%)

267 (10.6%)

87 (3.4%)

32 (1.3%)

 

2523 (100%)

Elevated

471 (88.5%)

40 (7.5%)

14 (2.6%)

7 (1.3%)

 

532 (100%)

Missing

1457 (96.1%)

43 (2.8%)

12 (0.8%)

4 (0.3%)

 

1516 (100%)

Hematocrit (%)

Anemia

576 (66.1%)

151 (17.3%)

124 (14.2%)

21 (2.4%)

< 0.001

872 (100%)

Normal**

2235 (85%)

274 (10.4%)

90 (3.4%)

31 (1.2%)

 

2630 (100%)

Elevated

505 (88.1%)

45 (7.9%)

16 (2.8%)

7 (1.2%)

 

573 (100%)

Missing

1464 (96.3%)

42 (2.8%)

11 (0.7%)

4 (0.3%)

 

1521 (100%)

White blood cell count (× 103/µL)

Leukocytopenia (< 4)

555 (80.6%)

99 (14.4%)

27 (3.9%)

8 (1.2%)

< 0.001

689 (100%)

Normal (4–11)

2628 (83.3%)

336 (10.7%)

149 (4.7%)

41 (1.3%)

 

3154 (100%)

Leukocytosis (≥ 11)

141 (59.2%)

35 (14.7%)

53 (22.3%)

9 (3.8%)

 

238 (100%)

Missing

1456 (96.1%)

42 (2.8%)

12 (0.8%)

5 (0.3%)

 

1515 (100%)

Lymphocyte count (× 103/µL)

Lymphocytopenia (< 1)

407 (51.8%)

196 (25%)

147 (18.7%)

35 (4.5%)

< 0.001

785 (100%)

Normal (1–4.8)

2871 (88.7%)

267 (8.2%)

77 (2.4%)

23 (0.7%)

 

3238 (100%)

Lymphocytosis (> 4.8)

33 (100%)

0 (0%)

0 (0%)

0 (0%)

 

33 (100%)

Missing

1469 (95.4%)

49 (3.2%)

17 (1.1%)

5 (0.3%)

 

1540 (100%)

Platelet count (× 103/µL)

Thrombocytopenia (< 150)

294 (58.8%)

106 (21.2%)

85 (17%)

15 (3%)

< 0.001

500 (100%)

Normal (150–450)

2971 (84.7%)

352 (10%)

142 (4%)

44 (1.3%)

 

3509 (100%)

Thrombocytosis (> 450)

59 (81.9%)

11 (15.3%)

2 (2.8%)

0 (0%)

 

72 (100%)

Missing

1456 (96.1%)

43 (2.8%)

12 (0.8%)

4 (0.3%)

 

1515 (100%)

  1. Values in cells and parentheses are the number and percentage of patients, respectively, except for the days to recovery or death. Patient characteristics in the external validation cohort is summarized in Supplementary Table S2.
  2. *Male, 13.8–17.2 g/dL; Female, 12.1–15.1 g/dL.
  3. **Male, 41–50%; Female, 36–48%.